NO851862L - Fremgangsmaate ved fremstilling av nye pyrrolobenzimidazoler - Google Patents
Fremgangsmaate ved fremstilling av nye pyrrolobenzimidazolerInfo
- Publication number
- NO851862L NO851862L NO851862A NO851862A NO851862L NO 851862 L NO851862 L NO 851862L NO 851862 A NO851862 A NO 851862A NO 851862 A NO851862 A NO 851862A NO 851862 L NO851862 L NO 851862L
- Authority
- NO
- Norway
- Prior art keywords
- indolin
- denotes
- nitro
- group
- pyridyl
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 14
- 238000002360 preparation method Methods 0.000 title claims description 6
- 150000001875 compounds Chemical class 0.000 claims description 141
- -1 methyl-ethyl Chemical group 0.000 claims description 71
- 125000000217 alkyl group Chemical group 0.000 claims description 29
- HXEXZNSKKSBTJR-UHFFFAOYSA-N 5h-pyrrolo[2,3-f]benzimidazol-6-one Chemical compound C=1C2=NC=NC2=CC2=CC(=O)NC2=1 HXEXZNSKKSBTJR-UHFFFAOYSA-N 0.000 claims description 24
- 229910052739 hydrogen Inorganic materials 0.000 claims description 18
- 239000001257 hydrogen Substances 0.000 claims description 17
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 15
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 14
- 125000003545 alkoxy group Chemical group 0.000 claims description 13
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 13
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 12
- 150000003839 salts Chemical class 0.000 claims description 11
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 10
- 125000003342 alkenyl group Chemical group 0.000 claims description 10
- 125000004432 carbon atom Chemical group C* 0.000 claims description 10
- 125000004356 hydroxy functional group Chemical group O* 0.000 claims description 10
- 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 claims description 9
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 9
- 229910052760 oxygen Inorganic materials 0.000 claims description 9
- 239000001301 oxygen Substances 0.000 claims description 9
- 125000000339 4-pyridyl group Chemical group N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 claims description 8
- 125000003282 alkyl amino group Chemical group 0.000 claims description 8
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 8
- 125000000717 hydrazino group Chemical group [H]N([*])N([H])[H] 0.000 claims description 8
- 150000007522 mineralic acids Chemical class 0.000 claims description 8
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 claims description 7
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 7
- TVLQBBHUNDMTEC-UHFFFAOYSA-N adibendan Chemical compound N=1C=2C=C3C(C)(C)C(=O)NC3=CC=2NC=1C1=CC=NC=C1 TVLQBBHUNDMTEC-UHFFFAOYSA-N 0.000 claims description 7
- 150000001732 carboxylic acid derivatives Chemical class 0.000 claims description 7
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 7
- 125000004663 dialkyl amino group Chemical group 0.000 claims description 7
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 7
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 7
- 125000002993 cycloalkylene group Chemical group 0.000 claims description 6
- 150000007524 organic acids Chemical class 0.000 claims description 6
- 125000004430 oxygen atom Chemical group O* 0.000 claims description 6
- 230000002378 acidificating effect Effects 0.000 claims description 5
- 125000005678 ethenylene group Chemical group [H]C([*:1])=C([H])[*:2] 0.000 claims description 5
- 125000005843 halogen group Chemical group 0.000 claims description 5
- 150000002367 halogens Chemical group 0.000 claims description 5
- 125000005842 heteroatom Chemical group 0.000 claims description 5
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 5
- 125000004076 pyridyl group Chemical group 0.000 claims description 5
- 229910052717 sulfur Inorganic materials 0.000 claims description 5
- 125000001118 alkylidene group Chemical group 0.000 claims description 4
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims description 4
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 claims description 4
- 229910052736 halogen Chemical group 0.000 claims description 4
- 235000005985 organic acids Nutrition 0.000 claims description 4
- 239000011593 sulfur Substances 0.000 claims description 4
- 239000005864 Sulphur Substances 0.000 claims description 3
- 125000002947 alkylene group Chemical group 0.000 claims description 3
- 239000003814 drug Substances 0.000 claims description 3
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 claims description 3
- 125000000654 isopropylidene group Chemical group C(C)(C)=* 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 125000001424 substituent group Chemical group 0.000 claims description 3
- IYABWNGZIDDRAK-UHFFFAOYSA-N allene Chemical group C=C=C IYABWNGZIDDRAK-UHFFFAOYSA-N 0.000 claims description 2
- 239000000969 carrier Substances 0.000 claims description 2
- DSGLEOFAHDZVCZ-UHFFFAOYSA-N ethyl 7-methyl-6-oxo-2-pyridin-4-yl-1,5-dihydropyrrolo[2,3-f]benzimidazole-7-carboxylate Chemical compound N=1C=2C=C3C(C(=O)OCC)(C)C(=O)NC3=CC=2NC=1C1=CC=NC=C1 DSGLEOFAHDZVCZ-UHFFFAOYSA-N 0.000 claims description 2
- 229940042795 hydrazides for tuberculosis treatment Drugs 0.000 claims description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 2
- 238000011282 treatment Methods 0.000 claims description 2
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 claims description 2
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 125000002573 ethenylidene group Chemical group [*]=C=C([H])[H] 0.000 claims 1
- 238000011321 prophylaxis Methods 0.000 claims 1
- ILVXOBCQQYKLDS-UHFFFAOYSA-N pyridine N-oxide Chemical group [O-][N+]1=CC=CC=C1 ILVXOBCQQYKLDS-UHFFFAOYSA-N 0.000 claims 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 145
- 239000000243 solution Substances 0.000 description 67
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 58
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 56
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 48
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 37
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 33
- 239000000047 product Substances 0.000 description 27
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 24
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 21
- 239000000203 mixture Substances 0.000 description 21
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 20
- 239000013078 crystal Substances 0.000 description 18
- 239000011541 reaction mixture Substances 0.000 description 16
- 229960000583 acetic acid Drugs 0.000 description 15
- 239000003054 catalyst Substances 0.000 description 14
- 238000010992 reflux Methods 0.000 description 14
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 12
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 12
- 238000001816 cooling Methods 0.000 description 12
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 11
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical group C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 11
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 11
- 238000006243 chemical reaction Methods 0.000 description 11
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 10
- 239000012362 glacial acetic acid Substances 0.000 description 8
- 238000003756 stirring Methods 0.000 description 8
- 239000000725 suspension Substances 0.000 description 8
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 7
- BNTRVUUJBGBGLZ-UHFFFAOYSA-N hydron;pyridine-4-carbonyl chloride;chloride Chemical compound Cl.ClC(=O)C1=CC=NC=C1 BNTRVUUJBGBGLZ-UHFFFAOYSA-N 0.000 description 7
- 238000006396 nitration reaction Methods 0.000 description 7
- 238000007363 ring formation reaction Methods 0.000 description 7
- 239000000741 silica gel Substances 0.000 description 7
- 229910002027 silica gel Inorganic materials 0.000 description 7
- 239000007858 starting material Substances 0.000 description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- 125000003277 amino group Chemical group 0.000 description 6
- 238000005984 hydrogenation reaction Methods 0.000 description 6
- 239000003380 propellant Substances 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- QGNQEODJYRGEJX-UHFFFAOYSA-N 4h-isoquinoline-1,3-dione Chemical compound C1=CC=C2C(=O)NC(=O)CC2=C1 QGNQEODJYRGEJX-UHFFFAOYSA-N 0.000 description 5
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 235000011114 ammonium hydroxide Nutrition 0.000 description 5
- 239000000460 chlorine Substances 0.000 description 5
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 5
- 229920006395 saturated elastomer Polymers 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 4
- KJIGCHMEHQYGPA-UHFFFAOYSA-N 6-amino-3,3-dimethyl-5-nitro-1h-indol-2-one Chemical compound NC1=C([N+]([O-])=O)C=C2C(C)(C)C(=O)NC2=C1 KJIGCHMEHQYGPA-UHFFFAOYSA-N 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 4
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 4
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 4
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- 230000001476 alcoholic effect Effects 0.000 description 4
- 239000002585 base Substances 0.000 description 4
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 4
- 229910052794 bromium Inorganic materials 0.000 description 4
- 229910052801 chlorine Inorganic materials 0.000 description 4
- 150000002431 hydrogen Chemical class 0.000 description 4
- 238000002844 melting Methods 0.000 description 4
- 230000008018 melting Effects 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 235000011149 sulphuric acid Nutrition 0.000 description 4
- HHDYSDWIZLXLDU-UHFFFAOYSA-N 5,6-diamino-3,3-dimethyl-1h-indol-2-one Chemical compound NC1=C(N)C=C2C(C)(C)C(=O)NC2=C1 HHDYSDWIZLXLDU-UHFFFAOYSA-N 0.000 description 3
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 3
- JYGFTBXVXVMTGB-UHFFFAOYSA-N Oxindol Natural products C1=CC=C2NC(=O)CC2=C1 JYGFTBXVXVMTGB-UHFFFAOYSA-N 0.000 description 3
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 3
- 229910021529 ammonia Inorganic materials 0.000 description 3
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 235000019439 ethyl acetate Nutrition 0.000 description 3
- 239000005457 ice water Substances 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 239000000543 intermediate Substances 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 239000012074 organic phase Substances 0.000 description 3
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Inorganic materials [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 3
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
- LBLYYCQCTBFVLH-UHFFFAOYSA-N 2-Methylbenzenesulfonic acid Chemical compound CC1=CC=CC=C1S(O)(=O)=O LBLYYCQCTBFVLH-UHFFFAOYSA-N 0.000 description 2
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 2
- QTBWCSDUVPXCOS-UHFFFAOYSA-N 3,3-diethyl-5-nitro-1h-indol-2-one Chemical compound C1=C([N+]([O-])=O)C=C2C(CC)(CC)C(=O)NC2=C1 QTBWCSDUVPXCOS-UHFFFAOYSA-N 0.000 description 2
- JTVMMOAEEVKAGQ-UHFFFAOYSA-N 3,3-dimethyl-6-nitro-1h-indol-2-one Chemical compound [O-][N+](=O)C1=CC=C2C(C)(C)C(=O)NC2=C1 JTVMMOAEEVKAGQ-UHFFFAOYSA-N 0.000 description 2
- IJRTYXJAHMLEJN-UHFFFAOYSA-N 4,4-dimethyl-7-nitroisoquinoline-1,3-dione Chemical compound [O-][N+](=O)C1=CC=C2C(C)(C)C(=O)NC(=O)C2=C1 IJRTYXJAHMLEJN-UHFFFAOYSA-N 0.000 description 2
- VVEJNQMYFCSJIN-UHFFFAOYSA-N 5,6-diamino-1,3-dihydroindol-2-one Chemical compound C1=C(N)C(N)=CC2=C1NC(=O)C2 VVEJNQMYFCSJIN-UHFFFAOYSA-N 0.000 description 2
- DEGHDGPZUTYKPJ-UHFFFAOYSA-N 5-amino-3,3-diethyl-6-nitro-1h-indol-2-one Chemical compound [O-][N+](=O)C1=C(N)C=C2C(CC)(CC)C(=O)NC2=C1 DEGHDGPZUTYKPJ-UHFFFAOYSA-N 0.000 description 2
- QYJOWWRUCCAUHW-UHFFFAOYSA-N 5-amino-3,3-dimethyl-1h-indol-2-one Chemical compound C1=C(N)C=C2C(C)(C)C(=O)NC2=C1 QYJOWWRUCCAUHW-UHFFFAOYSA-N 0.000 description 2
- IWARVYFPBLDOAK-UHFFFAOYSA-N 6-amino-3,3-dimethyl-1h-indol-2-one Chemical compound NC1=CC=C2C(C)(C)C(=O)NC2=C1 IWARVYFPBLDOAK-UHFFFAOYSA-N 0.000 description 2
- LFPZWYXMOOBNEU-UHFFFAOYSA-N 6-amino-3-(2-methylpropyl)-5-nitro-1,3-dihydroindol-2-one Chemical compound NC1=C([N+]([O-])=O)C=C2C(CC(C)C)C(=O)NC2=C1 LFPZWYXMOOBNEU-UHFFFAOYSA-N 0.000 description 2
- ZFNKZZWBTLPWQA-UHFFFAOYSA-N 7-(2-methylpropyl)-2-pyridin-4-yl-5,7-dihydro-1h-pyrrolo[2,3-f]benzimidazol-6-one Chemical compound N=1C=2C=C3C(CC(C)C)C(=O)NC3=CC=2NC=1C1=CC=NC=C1 ZFNKZZWBTLPWQA-UHFFFAOYSA-N 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 2
- RGSFGYAAUTVSQA-UHFFFAOYSA-N Cyclopentane Chemical compound C1CCCC1 RGSFGYAAUTVSQA-UHFFFAOYSA-N 0.000 description 2
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- AMIMRNSIRUDHCM-UHFFFAOYSA-N Isopropylaldehyde Chemical compound CC(C)C=O AMIMRNSIRUDHCM-UHFFFAOYSA-N 0.000 description 2
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 2
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 230000021736 acetylation Effects 0.000 description 2
- 238000006640 acetylation reaction Methods 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 150000001299 aldehydes Chemical class 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 150000008064 anhydrides Chemical class 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 150000001733 carboxylic acid esters Chemical class 0.000 description 2
- 238000009903 catalytic hydrogenation reaction Methods 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 2
- DNDJWJTURREHOK-UHFFFAOYSA-N ethyl 3-methyl-5-nitro-2-oxo-6-(pyridine-4-carbonylamino)-1h-indole-3-carboxylate Chemical compound [O-][N+](=O)C=1C=C2C(C(=O)OCC)(C)C(=O)NC2=CC=1NC(=O)C1=CC=NC=C1 DNDJWJTURREHOK-UHFFFAOYSA-N 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 239000011630 iodine Substances 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 2
- TWBYWOBDOCUKOW-UHFFFAOYSA-N isonicotinic acid Chemical compound OC(=O)C1=CC=NC=C1 TWBYWOBDOCUKOW-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- YCOXTAKXAKWZBY-UHFFFAOYSA-N n-(2-oxo-1,3-dihydroindol-6-yl)pyridine-4-carboxamide Chemical compound C=1C=C2CC(=O)NC2=CC=1NC(=O)C1=CC=NC=C1 YCOXTAKXAKWZBY-UHFFFAOYSA-N 0.000 description 2
- XNKHQYMRJZDJSE-UHFFFAOYSA-N n-(3,3-diethyl-6-nitro-2-oxo-1h-indol-5-yl)acetamide Chemical compound [O-][N+](=O)C1=C(NC(C)=O)C=C2C(CC)(CC)C(=O)NC2=C1 XNKHQYMRJZDJSE-UHFFFAOYSA-N 0.000 description 2
- VQVQHAMZTYAWIE-UHFFFAOYSA-N n-(3,3-dimethyl-5-nitro-2-oxo-1h-indol-6-yl)acetamide Chemical compound C1=C([N+]([O-])=O)C(NC(=O)C)=CC2=C1C(C)(C)C(=O)N2 VQVQHAMZTYAWIE-UHFFFAOYSA-N 0.000 description 2
- FBOGORGWSCLBEP-UHFFFAOYSA-N n-(3,3-dimethyl-5-nitro-2-oxo-1h-indol-6-yl)pyridine-4-carboxamide Chemical compound [O-][N+](=O)C=1C=C2C(C)(C)C(=O)NC2=CC=1NC(=O)C1=CC=NC=C1 FBOGORGWSCLBEP-UHFFFAOYSA-N 0.000 description 2
- KIJUNYWZAFNWAM-UHFFFAOYSA-N n-(5-nitro-2-oxo-1,3-dihydroindol-6-yl)pyridine-4-carboxamide Chemical compound [O-][N+](=O)C1=CC=2CC(=O)NC=2C=C1NC(=O)C1=CC=NC=C1 KIJUNYWZAFNWAM-UHFFFAOYSA-N 0.000 description 2
- DKXFSBCDDDQJBW-UHFFFAOYSA-N n-[3-(2-methylpropyl)-2-oxo-1,3-dihydroindol-6-yl]acetamide Chemical compound CC(=O)NC1=CC=C2C(CC(C)C)C(=O)NC2=C1 DKXFSBCDDDQJBW-UHFFFAOYSA-N 0.000 description 2
- PGMCZQZYPPPTOW-UHFFFAOYSA-N n-[3-(2-methylpropyl)-5-nitro-2-oxo-1,3-dihydroindol-6-yl]acetamide Chemical compound CC(=O)NC1=C([N+]([O-])=O)C=C2C(CC(C)C)C(=O)NC2=C1 PGMCZQZYPPPTOW-UHFFFAOYSA-N 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 229910052763 palladium Inorganic materials 0.000 description 2
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Substances [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 125000006239 protecting group Chemical group 0.000 description 2
- BKOVMXWXILSWCU-UHFFFAOYSA-N pyrrolo[3,2-e]benzimidazole Chemical class C1=CC2=NC=CC2=C2N=CN=C21 BKOVMXWXILSWCU-UHFFFAOYSA-N 0.000 description 2
- 239000011877 solvent mixture Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
- KHZHJGIOIIUHOO-UHFFFAOYSA-N 2-(2,4-diaminophenyl)acetic acid Chemical class NC1=CC=C(CC(O)=O)C(N)=C1 KHZHJGIOIIUHOO-UHFFFAOYSA-N 0.000 description 1
- YGSIETZSUHVPBE-UHFFFAOYSA-N 2-methoxy-6-methylpyridine-3-carbaldehyde Chemical compound COC1=NC(C)=CC=C1C=O YGSIETZSUHVPBE-UHFFFAOYSA-N 0.000 description 1
- GDPPKVKNRURIJC-UHFFFAOYSA-N 2-pyridin-3-yl-5,7-dihydro-1h-pyrrolo[2,3-f]benzimidazol-6-one Chemical compound N1C=2C=C3NC(=O)CC3=CC=2N=C1C1=CC=CN=C1 GDPPKVKNRURIJC-UHFFFAOYSA-N 0.000 description 1
- AFGGRDIUUMYLED-UHFFFAOYSA-N 2-pyridin-4-yl-5,7-dihydro-1h-pyrrolo[2,3-f]benzimidazol-6-one Chemical compound N1C=2C=C3NC(=O)CC3=CC=2N=C1C1=CC=NC=C1 AFGGRDIUUMYLED-UHFFFAOYSA-N 0.000 description 1
- KVLGLCIHQZYUTM-UHFFFAOYSA-N 2-pyridin-4-yl-5,7-dihydro-1h-pyrrolo[2,3-f]benzimidazol-6-one;hydrochloride Chemical compound Cl.N1C=2C=C3NC(=O)CC3=CC=2N=C1C1=CC=NC=C1 KVLGLCIHQZYUTM-UHFFFAOYSA-N 0.000 description 1
- JMTMSDXUXJISAY-UHFFFAOYSA-N 2H-benzotriazol-4-ol Chemical compound OC1=CC=CC2=C1N=NN2 JMTMSDXUXJISAY-UHFFFAOYSA-N 0.000 description 1
- JOAHCWIICCHHOU-UHFFFAOYSA-N 3,3-diethyl-1h-indol-2-one Chemical compound C1=CC=C2C(CC)(CC)C(=O)NC2=C1 JOAHCWIICCHHOU-UHFFFAOYSA-N 0.000 description 1
- OPKXYHAKILSTPF-UHFFFAOYSA-N 3,3-dimethyl-1,2-dihydroindole-5,6-diamine Chemical compound NC1=C(N)C=C2C(C)(C)CNC2=C1 OPKXYHAKILSTPF-UHFFFAOYSA-N 0.000 description 1
- UMHSOWVJQJFESZ-UHFFFAOYSA-N 3,3-dimethyl-5-nitro-1h-indol-2-one Chemical compound C1=C([N+]([O-])=O)C=C2C(C)(C)C(=O)NC2=C1 UMHSOWVJQJFESZ-UHFFFAOYSA-N 0.000 description 1
- XCFUPEXSVHKEFA-UHFFFAOYSA-N 3-acetyl-5,6-diamino-1,3-dihydroindol-2-one Chemical compound NC1=C(N)C=C2C(C(=O)C)C(=O)NC2=C1 XCFUPEXSVHKEFA-UHFFFAOYSA-N 0.000 description 1
- NWIOJBFDUIVQLK-UHFFFAOYSA-N 3-acetyl-5,6-diamino-3-methyl-1h-indol-2-one Chemical compound NC1=C(N)C=C2C(C(=O)C)(C)C(=O)NC2=C1 NWIOJBFDUIVQLK-UHFFFAOYSA-N 0.000 description 1
- MUQRBAKXNSTYIQ-UHFFFAOYSA-N 3-acetyl-5-amino-3-methyl-6-nitro-1h-indol-2-one Chemical compound [O-][N+](=O)C1=C(N)C=C2C(C(=O)C)(C)C(=O)NC2=C1 MUQRBAKXNSTYIQ-UHFFFAOYSA-N 0.000 description 1
- ULDNOSCPAYRPBB-UHFFFAOYSA-N 3-acetyl-5-amino-6-nitro-1,3-dihydroindol-2-one Chemical compound [O-][N+](=O)C1=C(N)C=C2C(C(=O)C)C(=O)NC2=C1 ULDNOSCPAYRPBB-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- JEHGATQUCUYHJL-UHFFFAOYSA-N 3-hydroxypyridine-4-carboxylic acid Chemical compound OC(=O)C1=CC=NC=C1O JEHGATQUCUYHJL-UHFFFAOYSA-N 0.000 description 1
- OHVMIPVAUWCHCL-UHFFFAOYSA-N 3-methylbenzene-1,2-dicarbonitrile Chemical compound CC1=CC=CC(C#N)=C1C#N OHVMIPVAUWCHCL-UHFFFAOYSA-N 0.000 description 1
- APSOEXOERLDHBY-UHFFFAOYSA-N 5,6-diamino-3,3-diethyl-1h-indol-2-one Chemical compound NC1=C(N)C=C2C(CC)(CC)C(=O)NC2=C1 APSOEXOERLDHBY-UHFFFAOYSA-N 0.000 description 1
- VJGJJAOBGIYFPO-UHFFFAOYSA-N 5,6-diamino-3-(2-methylpropyl)-1,3-dihydroindol-2-one Chemical compound NC1=C(N)C=C2C(CC(C)C)C(=O)NC2=C1 VJGJJAOBGIYFPO-UHFFFAOYSA-N 0.000 description 1
- WBZSJNBIAZUUEG-UHFFFAOYSA-N 5,6-diamino-3-cyclopentyl-1,3-dihydroindol-2-one Chemical compound C1=2C=C(N)C(N)=CC=2NC(=O)C1C1CCCC1 WBZSJNBIAZUUEG-UHFFFAOYSA-N 0.000 description 1
- FUNGHCVNHCSELX-UHFFFAOYSA-N 5,6-diamino-3-propan-2-yl-1,3-dihydroindol-2-one Chemical compound NC1=C(N)C=C2C(C(C)C)C(=O)NC2=C1 FUNGHCVNHCSELX-UHFFFAOYSA-N 0.000 description 1
- WSPRZQBQPDVXOA-UHFFFAOYSA-N 5-amino-3,3-dimethyl-6-nitro-1h-indol-2-one Chemical compound [O-][N+](=O)C1=C(N)C=C2C(C)(C)C(=O)NC2=C1 WSPRZQBQPDVXOA-UHFFFAOYSA-N 0.000 description 1
- MPYHFXWJKIUGJV-UHFFFAOYSA-N 5-amino-3-ethyl-6-nitro-1,3-dihydroindol-2-one Chemical compound [O-][N+](=O)C1=C(N)C=C2C(CC)C(=O)NC2=C1 MPYHFXWJKIUGJV-UHFFFAOYSA-N 0.000 description 1
- JQCGHRDKVZPCRO-UHFFFAOYSA-N 5-nitro-1,3-dihydroindol-2-one Chemical compound [O-][N+](=O)C1=CC=C2NC(=O)CC2=C1 JQCGHRDKVZPCRO-UHFFFAOYSA-N 0.000 description 1
- KRMASVGZYNXXTG-UHFFFAOYSA-N 6-amino-1,3-dihydroindol-2-one;hydrochloride Chemical compound Cl.NC1=CC=C2CC(=O)NC2=C1 KRMASVGZYNXXTG-UHFFFAOYSA-N 0.000 description 1
- UZQHOVHXUAXZHJ-UHFFFAOYSA-N 6-amino-5-nitro-1,3-dihydroindol-2-one Chemical compound C1=C([N+]([O-])=O)C(N)=CC2=C1CC(=O)N2 UZQHOVHXUAXZHJ-UHFFFAOYSA-N 0.000 description 1
- GFVTYBUTHKRKAA-UHFFFAOYSA-N 6-amino-5-nitro-3-propan-2-yl-1,3-dihydroindol-2-one Chemical compound NC1=C([N+]([O-])=O)C=C2C(C(C)C)C(=O)NC2=C1 GFVTYBUTHKRKAA-UHFFFAOYSA-N 0.000 description 1
- XPWULXJNOWVIDV-UHFFFAOYSA-N 7,7-diethyl-2-(2-pyridin-4-ylethyl)-1,5-dihydropyrrolo[2,3-f]benzimidazol-6-one Chemical compound N=1C=2C=C3C(CC)(CC)C(=O)NC3=CC=2NC=1CCC1=CC=NC=C1 XPWULXJNOWVIDV-UHFFFAOYSA-N 0.000 description 1
- DARBXUAGNYAGSH-UHFFFAOYSA-N 7,7-diethyl-2-pyridin-3-yl-1,5-dihydropyrrolo[2,3-f]benzimidazol-6-one Chemical compound N=1C=2C=C3C(CC)(CC)C(=O)NC3=CC=2NC=1C1=CC=CN=C1 DARBXUAGNYAGSH-UHFFFAOYSA-N 0.000 description 1
- FZHIVMNOQKIJIQ-UHFFFAOYSA-N 7,7-dimethyl-2-(2-pyridin-4-ylethenyl)-1,5-dihydropyrrolo[2,3-f]benzimidazol-6-one Chemical compound N=1C=2C=C3C(C)(C)C(=O)NC3=CC=2NC=1C=CC1=CC=NC=C1 FZHIVMNOQKIJIQ-UHFFFAOYSA-N 0.000 description 1
- TXWFKBXRSXVADD-UHFFFAOYSA-N 7,7-dimethyl-2-(pyridin-3-ylmethyl)-1,5-dihydropyrrolo[2,3-f]benzimidazol-6-one Chemical compound N1C=2C=C3C(C)(C)C(=O)NC3=CC=2N=C1CC1=CC=CN=C1 TXWFKBXRSXVADD-UHFFFAOYSA-N 0.000 description 1
- LIQVASFSSLEVAQ-UHFFFAOYSA-N 7,7-dimethyl-2-(pyridin-4-ylmethyl)-1,5-dihydropyrrolo[2,3-f]benzimidazol-6-one Chemical compound N=1C=2C=C3C(C)(C)C(=O)NC3=CC=2NC=1CC1=CC=NC=C1 LIQVASFSSLEVAQ-UHFFFAOYSA-N 0.000 description 1
- AZIHVKYVXWRPBZ-UHFFFAOYSA-N 7,7-dimethyl-2-pyridin-3-yl-1,5-dihydropyrrolo[2,3-f]benzimidazole-6-thione Chemical compound N1C=2C=C3C(C)(C)C(=S)NC3=CC=2N=C1C1=CC=CN=C1 AZIHVKYVXWRPBZ-UHFFFAOYSA-N 0.000 description 1
- GPDITTJOMWFEJS-UHFFFAOYSA-N 7,7-dimethyl-2-pyridin-4-yl-1,5-dihydropyrrolo[2,3-f]benzimidazole-6-thione Chemical compound N1C=2C=C3C(C)(C)C(=S)NC3=CC=2N=C1C1=CC=NC=C1 GPDITTJOMWFEJS-UHFFFAOYSA-N 0.000 description 1
- XGCVNFBAYHPBJK-UHFFFAOYSA-N 7-(2-methylpropyl)-2-pyridin-3-yl-5,7-dihydro-1h-pyrrolo[2,3-f]benzimidazol-6-one Chemical compound N1C=2C=C3C(CC(C)C)C(=O)NC3=CC=2N=C1C1=CC=CN=C1 XGCVNFBAYHPBJK-UHFFFAOYSA-N 0.000 description 1
- CUEUMKAZVKNWGI-UHFFFAOYSA-N 7-acetyl-7-methyl-2-pyridin-4-yl-1,5-dihydropyrrolo[2,3-f]benzimidazol-6-one Chemical compound N=1C=2C=C3C(C(=O)C)(C)C(=O)NC3=CC=2NC=1C1=CC=NC=C1 CUEUMKAZVKNWGI-UHFFFAOYSA-N 0.000 description 1
- WZSOWHIBYMYMKD-UHFFFAOYSA-N 7-cyclohexyl-2-pyridin-3-yl-5,7-dihydro-1h-pyrrolo[2,3-f]benzimidazol-6-one Chemical compound O=C1NC2=CC=3NC(C=4C=NC=CC=4)=NC=3C=C2C1C1CCCCC1 WZSOWHIBYMYMKD-UHFFFAOYSA-N 0.000 description 1
- VYQAITOUQDWIOQ-UHFFFAOYSA-N 7-cyclohexyl-2-pyridin-4-yl-5,7-dihydro-1h-pyrrolo[2,3-f]benzimidazol-6-one Chemical compound O=C1NC2=CC=3N=C(C=4C=CN=CC=4)NC=3C=C2C1C1CCCCC1 VYQAITOUQDWIOQ-UHFFFAOYSA-N 0.000 description 1
- JFKHDIDEHMZPQZ-UHFFFAOYSA-N 7-cyclopentyl-2-pyridin-3-yl-5,7-dihydro-1h-pyrrolo[2,3-f]benzimidazol-6-one Chemical compound O=C1NC2=CC=3NC(C=4C=NC=CC=4)=NC=3C=C2C1C1CCCC1 JFKHDIDEHMZPQZ-UHFFFAOYSA-N 0.000 description 1
- AKEIDEMGMNBECF-UHFFFAOYSA-N 7-ethyl-2-pyridin-3-yl-5,7-dihydro-1h-pyrrolo[2,3-f]benzimidazole-6-thione Chemical compound N=1C=2C=C3C(CC)C(=S)NC3=CC=2NC=1C1=CC=CN=C1 AKEIDEMGMNBECF-UHFFFAOYSA-N 0.000 description 1
- HCANWDQKKUWHBB-UHFFFAOYSA-N 7-ethyl-2-pyridin-4-yl-5,7-dihydro-1h-pyrrolo[2,3-f]benzimidazole-6-thione Chemical compound N=1C=2C=C3C(CC)C(=S)NC3=CC=2NC=1C1=CC=NC=C1 HCANWDQKKUWHBB-UHFFFAOYSA-N 0.000 description 1
- FIHLRRFUODTNRJ-UHFFFAOYSA-N 7-methyl-2-pyridin-2-yl-5,7-dihydro-1h-pyrrolo[2,3-f]benzimidazole-6-thione Chemical compound N=1C=2C=C3C(C)C(=S)NC3=CC=2NC=1C1=CC=CC=N1 FIHLRRFUODTNRJ-UHFFFAOYSA-N 0.000 description 1
- LXFXESKMPBQOCN-UHFFFAOYSA-N 7-methyl-2-pyridin-3-yl-5,7-dihydro-1h-pyrrolo[2,3-f]benzimidazole-6-thione Chemical compound N=1C=2C=C3C(C)C(=S)NC3=CC=2NC=1C1=CC=CN=C1 LXFXESKMPBQOCN-UHFFFAOYSA-N 0.000 description 1
- SVBFRGNMQAVBAP-UHFFFAOYSA-N 7-methyl-2-pyridin-4-yl-5,7-dihydro-1h-pyrrolo[2,3-f]benzimidazole-6-thione Chemical compound N=1C=2C=C3C(C)C(=S)NC3=CC=2NC=1C1=CC=NC=C1 SVBFRGNMQAVBAP-UHFFFAOYSA-N 0.000 description 1
- XDQXNVSKMMZFQG-UHFFFAOYSA-N 7-methyl-6-oxo-2-pyridin-3-yl-1,5-dihydropyrrolo[2,3-f]benzimidazole-7-carbohydrazide Chemical compound N=1C=2C=C3C(C)(C(=O)NN)C(=O)NC3=CC=2NC=1C1=CC=CN=C1 XDQXNVSKMMZFQG-UHFFFAOYSA-N 0.000 description 1
- QDLQPDFTNQHWIB-UHFFFAOYSA-N 7-methyl-6-oxo-2-pyridin-3-yl-1,5-dihydropyrrolo[2,3-f]benzimidazole-7-carbonitrile Chemical compound N=1C=2C=C3C(C)(C#N)C(=O)NC3=CC=2NC=1C1=CC=CN=C1 QDLQPDFTNQHWIB-UHFFFAOYSA-N 0.000 description 1
- ODCBBLNOOBCTAE-UHFFFAOYSA-N 7-methyl-6-oxo-2-pyridin-3-yl-1,5-dihydropyrrolo[2,3-f]benzimidazole-7-carboxamide Chemical compound N=1C=2C=C3C(C)(C(N)=O)C(=O)NC3=CC=2NC=1C1=CC=CN=C1 ODCBBLNOOBCTAE-UHFFFAOYSA-N 0.000 description 1
- YVXWETMTHPARMJ-UHFFFAOYSA-N 7-methyl-6-oxo-2-pyridin-4-yl-1,5-dihydropyrrolo[2,3-f]benzimidazole-7-carbohydrazide Chemical compound N=1C=2C=C3C(C)(C(=O)NN)C(=O)NC3=CC=2NC=1C1=CC=NC=C1 YVXWETMTHPARMJ-UHFFFAOYSA-N 0.000 description 1
- GSLAIWFAJNVYOW-UHFFFAOYSA-N 7-methyl-6-oxo-2-pyridin-4-yl-1,5-dihydropyrrolo[2,3-f]benzimidazole-7-carbonitrile Chemical compound N=1C=2C=C3C(C)(C#N)C(=O)NC3=CC=2NC=1C1=CC=NC=C1 GSLAIWFAJNVYOW-UHFFFAOYSA-N 0.000 description 1
- RLBYCRZMUOEVAZ-UHFFFAOYSA-N 7-pentan-3-yl-2-pyridin-3-yl-5,7-dihydro-1h-pyrrolo[2,3-f]benzimidazol-6-one Chemical compound N1C=2C=C3C(C(CC)CC)C(=O)NC3=CC=2N=C1C1=CC=CN=C1 RLBYCRZMUOEVAZ-UHFFFAOYSA-N 0.000 description 1
- HPZXEVSFIYJDPV-UHFFFAOYSA-N 7-pentan-3-yl-2-pyridin-4-yl-5,7-dihydro-1h-pyrrolo[2,3-f]benzimidazol-6-one Chemical compound N1C=2C=C3C(C(CC)CC)C(=O)NC3=CC=2N=C1C1=CC=NC=C1 HPZXEVSFIYJDPV-UHFFFAOYSA-N 0.000 description 1
- ZGLYCVJRQXMQTD-UHFFFAOYSA-N 7-propan-2-yl-2-pyridin-3-yl-5,7-dihydro-1h-pyrrolo[2,3-f]benzimidazol-6-one Chemical compound N=1C=2C=C3C(C(C)C)C(=O)NC3=CC=2NC=1C1=CC=CN=C1 ZGLYCVJRQXMQTD-UHFFFAOYSA-N 0.000 description 1
- DMJHHSXUJWWPEP-UHFFFAOYSA-N 7-propan-2-ylidene-2-pyridin-3-yl-1,5-dihydropyrrolo[2,3-f]benzimidazol-6-one Chemical compound N=1C=2C=C3C(=C(C)C)C(=O)NC3=CC=2NC=1C1=CC=CN=C1 DMJHHSXUJWWPEP-UHFFFAOYSA-N 0.000 description 1
- HQHNVOPNZBWYBE-UHFFFAOYSA-N 7-propan-2-ylidene-2-pyridin-4-yl-1,5-dihydropyrrolo[2,3-f]benzimidazol-6-one Chemical compound N=1C=2C=C3C(=C(C)C)C(=O)NC3=CC=2NC=1C1=CC=NC=C1 HQHNVOPNZBWYBE-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- VYZAHLCBVHPDDF-UHFFFAOYSA-N Dinitrochlorobenzene Chemical compound [O-][N+](=O)C1=CC=C(Cl)C([N+]([O-])=O)=C1 VYZAHLCBVHPDDF-UHFFFAOYSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 241000206672 Gelidium Species 0.000 description 1
- 241000243251 Hydra Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 239000002841 Lewis acid Substances 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 150000001204 N-oxides Chemical class 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 239000007868 Raney catalyst Substances 0.000 description 1
- 229910000564 Raney nickel Inorganic materials 0.000 description 1
- 239000002262 Schiff base Substances 0.000 description 1
- 150000004753 Schiff bases Chemical class 0.000 description 1
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- 229910021626 Tin(II) chloride Inorganic materials 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 230000000397 acetylating effect Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 description 1
- 230000002152 alkylating effect Effects 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 235000019568 aromas Nutrition 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- UQRTVNHZSVCGMI-UHFFFAOYSA-N benzimidazole-5-thione Chemical compound S=C1C=CC2=NC=NC2=C1 UQRTVNHZSVCGMI-UHFFFAOYSA-N 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- UDYGXWPMSJPFDG-UHFFFAOYSA-M benzyl(tributyl)azanium;bromide Chemical compound [Br-].CCCC[N+](CCCC)(CCCC)CC1=CC=CC=C1 UDYGXWPMSJPFDG-UHFFFAOYSA-M 0.000 description 1
- 210000001772 blood platelet Anatomy 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 238000003763 carbonization Methods 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 150000001805 chlorine compounds Chemical class 0.000 description 1
- 239000007979 citrate buffer Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 239000008139 complexing agent Substances 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- HCAJEUSONLESMK-UHFFFAOYSA-N cyclohexylsulfamic acid Chemical compound OS(=O)(=O)NC1CCCCC1 HCAJEUSONLESMK-UHFFFAOYSA-N 0.000 description 1
- PWAPCRSSMCLZHG-UHFFFAOYSA-N cyclopentylidene Chemical group [C]1CCCC1 PWAPCRSSMCLZHG-UHFFFAOYSA-N 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000010511 deprotection reaction Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- DDIVFYFXZHMEOW-UHFFFAOYSA-N diethyl 2-(2,4-dinitrophenyl)-2-methylpropanedioate Chemical compound CCOC(=O)C(C)(C(=O)OCC)C1=CC=C([N+]([O-])=O)C=C1[N+]([O-])=O DDIVFYFXZHMEOW-UHFFFAOYSA-N 0.000 description 1
- UPQZOUHVTJNGFK-UHFFFAOYSA-N diethyl 2-methylpropanedioate Chemical compound CCOC(=O)C(C)C(=O)OCC UPQZOUHVTJNGFK-UHFFFAOYSA-N 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 229960004756 ethanol Drugs 0.000 description 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
- SVZLNBOHXQYADY-UHFFFAOYSA-N ethyl 3-ethyl-5-nitro-2-oxo-6-(pyridine-4-carbonylamino)-1h-indole-3-carboxylate Chemical compound [O-][N+](=O)C=1C=C2C(C(=O)OCC)(CC)C(=O)NC2=CC=1NC(=O)C1=CC=NC=C1 SVZLNBOHXQYADY-UHFFFAOYSA-N 0.000 description 1
- HPZFWLPPJRKELU-UHFFFAOYSA-N ethyl 3-ethyl-6-nitro-2-oxo-5-(pyridine-4-carbonylamino)-1h-indole-3-carboxylate Chemical compound C1=C2C(C(=O)OCC)(CC)C(=O)NC2=CC([N+]([O-])=O)=C1NC(=O)C1=CC=NC=C1 HPZFWLPPJRKELU-UHFFFAOYSA-N 0.000 description 1
- RWRNJGGXLPIWKA-UHFFFAOYSA-N ethyl 3-methyl-2-oxo-6-(pyridine-4-carbonylamino)-1h-indole-3-carboxylate Chemical compound C=1C=C2C(C(=O)OCC)(C)C(=O)NC2=CC=1NC(=O)C1=CC=NC=C1 RWRNJGGXLPIWKA-UHFFFAOYSA-N 0.000 description 1
- IMTGLPYFYQLBTE-UHFFFAOYSA-N ethyl 3-methyl-5-nitro-2-oxo-6-(pyridine-3-carbonylamino)-1h-indole-3-carboxylate Chemical compound [O-][N+](=O)C=1C=C2C(C(=O)OCC)(C)C(=O)NC2=CC=1NC(=O)C1=CC=CN=C1 IMTGLPYFYQLBTE-UHFFFAOYSA-N 0.000 description 1
- FGGQYTOLGLNHKY-UHFFFAOYSA-N ethyl 3-methyl-6-nitro-2-oxo-5-(pyridine-3-carbonylamino)-1h-indole-3-carboxylate Chemical compound C1=C2C(C(=O)OCC)(C)C(=O)NC2=CC([N+]([O-])=O)=C1NC(=O)C1=CC=CN=C1 FGGQYTOLGLNHKY-UHFFFAOYSA-N 0.000 description 1
- DMSMTACTGPAJBI-UHFFFAOYSA-N ethyl 3-methyl-6-nitro-2-oxo-5-(pyridine-4-carbonylamino)-1h-indole-3-carboxylate Chemical compound C1=C2C(C(=O)OCC)(C)C(=O)NC2=CC([N+]([O-])=O)=C1NC(=O)C1=CC=NC=C1 DMSMTACTGPAJBI-UHFFFAOYSA-N 0.000 description 1
- OSNLMWCVAKPBOT-UHFFFAOYSA-N ethyl 5-amino-3-methyl-2-oxo-6-(pyridine-4-carbonylamino)-1h-indole-3-carboxylate Chemical compound NC=1C=C2C(C(=O)OCC)(C)C(=O)NC2=CC=1NC(=O)C1=CC=NC=C1 OSNLMWCVAKPBOT-UHFFFAOYSA-N 0.000 description 1
- ZVBCDNLJIJOQMV-UHFFFAOYSA-N ethyl 5-amino-6-nitro-2-oxo-1,3-dihydroindole-3-carboxylate Chemical compound [O-][N+](=O)C1=C(N)C=C2C(C(=O)OCC)C(=O)NC2=C1 ZVBCDNLJIJOQMV-UHFFFAOYSA-N 0.000 description 1
- YBOLMCFPLGZQDE-UHFFFAOYSA-N ethyl 6-amino-3-methyl-2-oxo-1h-indole-3-carboxylate Chemical compound NC1=CC=C2C(C(=O)OCC)(C)C(=O)NC2=C1 YBOLMCFPLGZQDE-UHFFFAOYSA-N 0.000 description 1
- NRVLQSLDTYNJSE-UHFFFAOYSA-N ethyl 6-oxo-2-pyridin-3-yl-5,7-dihydro-1h-pyrrolo[2,3-f]benzimidazole-7-carboxylate Chemical compound N=1C=2C=C3C(C(=O)OCC)C(=O)NC3=CC=2NC=1C1=CC=CN=C1 NRVLQSLDTYNJSE-UHFFFAOYSA-N 0.000 description 1
- FMJROIYGRIOGRA-UHFFFAOYSA-N ethyl 6-oxo-2-pyridin-4-yl-5,7-dihydro-1h-pyrrolo[2,3-f]benzimidazole-7-carboxylate Chemical compound N=1C=2C=C3C(C(=O)OCC)C(=O)NC3=CC=2NC=1C1=CC=NC=C1 FMJROIYGRIOGRA-UHFFFAOYSA-N 0.000 description 1
- URLVGWHOJMBTMM-UHFFFAOYSA-N ethyl 7-ethyl-6-oxo-2-pyridin-3-yl-1,5-dihydropyrrolo[2,3-f]benzimidazole-7-carboxylate Chemical compound N=1C=2C=C3C(C(=O)OCC)(CC)C(=O)NC3=CC=2NC=1C1=CC=CN=C1 URLVGWHOJMBTMM-UHFFFAOYSA-N 0.000 description 1
- QRVVEQBHJJRCEU-UHFFFAOYSA-N ethyl 7-ethyl-6-oxo-2-pyridin-4-yl-1,5-dihydropyrrolo[2,3-f]benzimidazole-7-carboxylate Chemical compound N=1C=2C=C3C(C(=O)OCC)(CC)C(=O)NC3=CC=2NC=1C1=CC=NC=C1 QRVVEQBHJJRCEU-UHFFFAOYSA-N 0.000 description 1
- OSAHUOYMAGJZGK-UHFFFAOYSA-N ethyl 7-methyl-6-oxo-2-pyridin-3-yl-1,5-dihydropyrrolo[2,3-f]benzimidazole-7-carboxylate Chemical compound N1C=2C=C3C(C(=O)OCC)(C)C(=O)NC3=CC=2N=C1C1=CC=CN=C1 OSAHUOYMAGJZGK-UHFFFAOYSA-N 0.000 description 1
- NWWZDXUTBHKXDU-UHFFFAOYSA-N ethyl 7-methyl-6-oxo-2-pyridin-4-yl-1,5-dihydropyrrolo[2,3-f]benzimidazole-7-carboxylate;hydrochloride Chemical compound Cl.N1C=2C=C3C(C(=O)OCC)(C)C(=O)NC3=CC=2N=C1C1=CC=NC=C1 NWWZDXUTBHKXDU-UHFFFAOYSA-N 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- DMEGYFMYUHOHGS-UHFFFAOYSA-N heptamethylene Natural products C1CCCCCC1 DMEGYFMYUHOHGS-UHFFFAOYSA-N 0.000 description 1
- 229920006158 high molecular weight polymer Polymers 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- NPZTUJOABDZTLV-UHFFFAOYSA-N hydroxybenzotriazole Substances O=C1C=CC=C2NNN=C12 NPZTUJOABDZTLV-UHFFFAOYSA-N 0.000 description 1
- 239000012442 inert solvent Substances 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- QRXWMOHMRWLFEY-UHFFFAOYSA-N isoniazide Chemical compound NNC(=O)C1=CC=NC=C1 QRXWMOHMRWLFEY-UHFFFAOYSA-N 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- CFHGBZLNZZVTAY-UHFFFAOYSA-N lawesson's reagent Chemical compound C1=CC(OC)=CC=C1P1(=S)SP(=S)(C=2C=CC(OC)=CC=2)S1 CFHGBZLNZZVTAY-UHFFFAOYSA-N 0.000 description 1
- 150000007517 lewis acids Chemical class 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 150000002690 malonic acid derivatives Chemical class 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 1
- ZOKQLMMQYVXILS-UHFFFAOYSA-N methyl 2-pyridin-4-ylacetate Chemical compound COC(=O)CC1=CC=NC=C1 ZOKQLMMQYVXILS-UHFFFAOYSA-N 0.000 description 1
- VRRSRFNZPWZJRV-UHFFFAOYSA-N methyl 3-methyl-5-nitro-2-oxo-6-(pyridine-4-carbonylamino)-1h-indole-3-carboxylate Chemical compound [O-][N+](=O)C=1C=C2C(C(=O)OC)(C)C(=O)NC2=CC=1NC(=O)C1=CC=NC=C1 VRRSRFNZPWZJRV-UHFFFAOYSA-N 0.000 description 1
- BLXDOXXUIFNGPY-UHFFFAOYSA-N methyl 3-methyl-6-nitro-2-oxo-5-(pyridine-3-carbonylamino)-1h-indole-3-carboxylate Chemical compound C1=C2C(C(=O)OC)(C)C(=O)NC2=CC([N+]([O-])=O)=C1NC(=O)C1=CC=CN=C1 BLXDOXXUIFNGPY-UHFFFAOYSA-N 0.000 description 1
- CMDJREOPXZVVMU-UHFFFAOYSA-N methyl 3-methyl-6-nitro-2-oxo-5-(pyridine-4-carbonylamino)-1h-indole-3-carboxylate Chemical compound C1=C2C(C(=O)OC)(C)C(=O)NC2=CC([N+]([O-])=O)=C1NC(=O)C1=CC=NC=C1 CMDJREOPXZVVMU-UHFFFAOYSA-N 0.000 description 1
- FWWRFKCUMGPEHG-UHFFFAOYSA-N methyl 5-amino-6-nitro-2-oxo-1,3-dihydroindole-3-carboxylate Chemical compound [O-][N+](=O)C1=C(N)C=C2C(C(=O)OC)C(=O)NC2=C1 FWWRFKCUMGPEHG-UHFFFAOYSA-N 0.000 description 1
- WOLXSJPYBABMNE-UHFFFAOYSA-N methyl 6-oxo-2-pyridin-3-yl-5,7-dihydro-1h-pyrrolo[2,3-f]benzimidazole-7-carboxylate Chemical compound N=1C=2C=C3C(C(=O)OC)C(=O)NC3=CC=2NC=1C1=CC=CN=C1 WOLXSJPYBABMNE-UHFFFAOYSA-N 0.000 description 1
- YVLXHRHNOPFXTO-UHFFFAOYSA-N methyl 6-oxo-2-pyridin-4-yl-5,7-dihydro-1h-pyrrolo[2,3-f]benzimidazole-7-carboxylate Chemical compound N=1C=2C=C3C(C(=O)OC)C(=O)NC3=CC=2NC=1C1=CC=NC=C1 YVLXHRHNOPFXTO-UHFFFAOYSA-N 0.000 description 1
- BWMBVLQRRJILNJ-UHFFFAOYSA-N methyl 7-methyl-6-oxo-2-pyridin-3-yl-1,5-dihydropyrrolo[2,3-f]benzimidazole-7-carboxylate Chemical compound N=1C=2C=C3C(C(=O)OC)(C)C(=O)NC3=CC=2NC=1C1=CC=CN=C1 BWMBVLQRRJILNJ-UHFFFAOYSA-N 0.000 description 1
- NZGHHVXMUVLUEC-UHFFFAOYSA-N methyl 7-methyl-6-oxo-2-pyridin-4-yl-1,5-dihydropyrrolo[2,3-f]benzimidazole-7-carboxylate Chemical compound N1C=2C=C3C(C(=O)OC)(C)C(=O)NC3=CC=2N=C1C1=CC=NC=C1 NZGHHVXMUVLUEC-UHFFFAOYSA-N 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 125000004458 methylaminocarbonyl group Chemical group [H]N(C(*)=O)C([H])([H])[H] 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- YLBYAZHPXJQIPP-UHFFFAOYSA-N n-(2-oxo-1,3-dihydroindol-6-yl)acetamide Chemical compound CC(=O)NC1=CC=C2CC(=O)NC2=C1 YLBYAZHPXJQIPP-UHFFFAOYSA-N 0.000 description 1
- ZUYBEKOIVNPYQM-UHFFFAOYSA-N n-(2-oxo-3-propan-2-ylidene-1h-indol-6-yl)acetamide Chemical compound CC(=O)NC1=CC=C2C(=C(C)C)C(=O)NC2=C1 ZUYBEKOIVNPYQM-UHFFFAOYSA-N 0.000 description 1
- IDNOWFZGVZCQCB-UHFFFAOYSA-N n-(2-oxo-3h-indol-1-yl)pyridine-4-carboxamide Chemical compound O=C1CC2=CC=CC=C2N1NC(=O)C1=CC=NC=C1 IDNOWFZGVZCQCB-UHFFFAOYSA-N 0.000 description 1
- ZMPNERYFOFSFCN-UHFFFAOYSA-N n-(3,3-diethyl-2-oxo-1h-indol-5-yl)acetamide Chemical compound C1=C(NC(C)=O)C=C2C(CC)(CC)C(=O)NC2=C1 ZMPNERYFOFSFCN-UHFFFAOYSA-N 0.000 description 1
- MIQSXMGZCHNVHZ-UHFFFAOYSA-N n-(3,3-dimethyl-2-oxo-1h-indol-5-yl)pyridine-3-carboxamide Chemical compound C1=C2C(C)(C)C(=O)NC2=CC=C1NC(=O)C1=CC=CN=C1 MIQSXMGZCHNVHZ-UHFFFAOYSA-N 0.000 description 1
- ZUOBPNNNPGUODS-UHFFFAOYSA-N n-(3,3-dimethyl-2-oxo-1h-indol-5-yl)pyridine-4-carboxamide Chemical compound C1=C2C(C)(C)C(=O)NC2=CC=C1NC(=O)C1=CC=NC=C1 ZUOBPNNNPGUODS-UHFFFAOYSA-N 0.000 description 1
- TWPASOHPNLHMES-UHFFFAOYSA-N n-(3,3-dimethyl-2-oxo-1h-indol-6-yl)acetamide Chemical compound CC(=O)NC1=CC=C2C(C)(C)C(=O)NC2=C1 TWPASOHPNLHMES-UHFFFAOYSA-N 0.000 description 1
- IYXCMTFSBUYZCT-UHFFFAOYSA-N n-(3,3-dimethyl-5-nitro-2-oxo-1h-indol-6-yl)pyridine-2-carboxamide Chemical compound [O-][N+](=O)C=1C=C2C(C)(C)C(=O)NC2=CC=1NC(=O)C1=CC=CC=N1 IYXCMTFSBUYZCT-UHFFFAOYSA-N 0.000 description 1
- DYFCJLLGQUGEKN-UHFFFAOYSA-N n-(3,3-dimethyl-5-nitro-2-sulfanylidene-1h-indol-6-yl)pyridine-2-carboxamide;n-(3,3-dimethyl-5-nitro-2-sulfanylidene-1h-indol-6-yl)pyridine-3-carboxamide;n-(3,3-dimethyl-5-nitro-2-sulfanylidene-1h-indol-6-yl)pyridine-4-carboxamide Chemical compound [O-][N+](=O)C=1C=C2C(C)(C)C(=S)NC2=CC=1NC(=O)C1=CC=NC=C1.[O-][N+](=O)C=1C=C2C(C)(C)C(=S)NC2=CC=1NC(=O)C1=CC=CN=C1.[O-][N+](=O)C=1C=C2C(C)(C)C(=S)NC2=CC=1NC(=O)C1=CC=CC=N1 DYFCJLLGQUGEKN-UHFFFAOYSA-N 0.000 description 1
- UBPWQQZBKHKWKX-UHFFFAOYSA-N n-(3,3-dimethyl-6-nitro-2-oxo-1h-indol-5-yl)pyridine-3-carboxamide Chemical compound C1=C2C(C)(C)C(=O)NC2=CC([N+]([O-])=O)=C1NC(=O)C1=CC=CN=C1 UBPWQQZBKHKWKX-UHFFFAOYSA-N 0.000 description 1
- GRHAHVCMBWLKPF-UHFFFAOYSA-N n-(3,3-dimethyl-6-nitro-2-oxo-1h-indol-5-yl)pyridine-4-carboxamide Chemical compound C1=C2C(C)(C)C(=O)NC2=CC([N+]([O-])=O)=C1NC(=O)C1=CC=NC=C1 GRHAHVCMBWLKPF-UHFFFAOYSA-N 0.000 description 1
- QXPFVJJIDKTICL-UHFFFAOYSA-N n-(3-acetyl-3-methyl-5-nitro-2-oxo-1h-indol-6-yl)pyridine-4-carboxamide Chemical compound [O-][N+](=O)C=1C=C2C(C(=O)C)(C)C(=O)NC2=CC=1NC(=O)C1=CC=NC=C1 QXPFVJJIDKTICL-UHFFFAOYSA-N 0.000 description 1
- WNAHJHGRUDXDQR-UHFFFAOYSA-N n-(3-acetyl-3-methyl-6-nitro-2-oxo-1h-indol-5-yl)pyridine-4-carboxamide Chemical compound C1=C2C(C(=O)C)(C)C(=O)NC2=CC([N+]([O-])=O)=C1NC(=O)C1=CC=NC=C1 WNAHJHGRUDXDQR-UHFFFAOYSA-N 0.000 description 1
- AHQJMDADUPATMD-UHFFFAOYSA-N n-(3-cyclohexyl-6-nitro-2-oxo-1,3-dihydroindol-5-yl)pyridine-4-carboxamide Chemical compound C1=2C=C(NC(=O)C=3C=CN=CC=3)C([N+](=O)[O-])=CC=2NC(=O)C1C1CCCCC1 AHQJMDADUPATMD-UHFFFAOYSA-N 0.000 description 1
- VGLLXNPIXHZUEM-UHFFFAOYSA-N n-(3-ethyl-5-nitro-2-sulfanylidene-1,3-dihydroindol-6-yl)pyridine-2-carboxamide;n-(3-ethyl-5-nitro-2-sulfanylidene-1,3-dihydroindol-6-yl)pyridine-3-carboxamide;n-(3-ethyl-5-nitro-2-sulfanylidene-1,3-dihydroindol-6-yl)pyridine-4-carboxamide Chemical compound [O-][N+](=O)C=1C=C2C(CC)C(=S)NC2=CC=1NC(=O)C1=CC=NC=C1.[O-][N+](=O)C=1C=C2C(CC)C(=S)NC2=CC=1NC(=O)C1=CC=CN=C1.[O-][N+](=O)C=1C=C2C(CC)C(=S)NC2=CC=1NC(=O)C1=CC=CC=N1 VGLLXNPIXHZUEM-UHFFFAOYSA-N 0.000 description 1
- RJMGBSMTURJWEE-UHFFFAOYSA-N n-(5-nitro-2-oxo-1,3-dihydroindol-6-yl)pyridine-3-carboxamide Chemical compound [O-][N+](=O)C1=CC=2CC(=O)NC=2C=C1NC(=O)C1=CC=CN=C1 RJMGBSMTURJWEE-UHFFFAOYSA-N 0.000 description 1
- CQGHYIMNLKNQDI-UHFFFAOYSA-N n-(5-nitro-2-oxo-3-pentan-3-yl-1,3-dihydroindol-6-yl)pyridine-3-carboxamide;n-(5-nitro-2-oxo-3-pentan-3-yl-1,3-dihydroindol-6-yl)pyridine-4-carboxamide;n-(5-nitro-2-oxo-3-propan-2-yl-1,3-dihydroindol-6-yl)pyridine-3-carboxamide Chemical compound [O-][N+](=O)C=1C=C2C(C(C)C)C(=O)NC2=CC=1NC(=O)C1=CC=CN=C1.[O-][N+](=O)C=1C=C2C(C(CC)CC)C(=O)NC2=CC=1NC(=O)C1=CC=NC=C1.[O-][N+](=O)C=1C=C2C(C(CC)CC)C(=O)NC2=CC=1NC(=O)C1=CC=CN=C1 CQGHYIMNLKNQDI-UHFFFAOYSA-N 0.000 description 1
- JZNZAQSAJPMQLS-UHFFFAOYSA-N n-(6-nitro-2-oxo-1,3-dihydroindol-5-yl)pyridine-3-carboxamide Chemical compound [O-][N+](=O)C1=CC=2NC(=O)CC=2C=C1NC(=O)C1=CC=CN=C1 JZNZAQSAJPMQLS-UHFFFAOYSA-N 0.000 description 1
- QEFDSTFIDXJYCX-UHFFFAOYSA-N n-(6-nitro-2-oxo-1,3-dihydroindol-5-yl)pyridine-4-carboxamide Chemical compound [O-][N+](=O)C1=CC=2NC(=O)CC=2C=C1NC(=O)C1=CC=NC=C1 QEFDSTFIDXJYCX-UHFFFAOYSA-N 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 150000005623 oxindoles Chemical class 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- HKOOXMFOFWEVGF-UHFFFAOYSA-N phenylhydrazine Chemical compound NNC1=CC=CC=C1 HKOOXMFOFWEVGF-UHFFFAOYSA-N 0.000 description 1
- 229940067157 phenylhydrazine Drugs 0.000 description 1
- 150000004031 phenylhydrazines Chemical class 0.000 description 1
- RLOWWWKZYUNIDI-UHFFFAOYSA-N phosphinic chloride Chemical compound ClP=O RLOWWWKZYUNIDI-UHFFFAOYSA-N 0.000 description 1
- CYQAYERJWZKYML-UHFFFAOYSA-N phosphorus pentasulfide Chemical compound S1P(S2)(=S)SP3(=S)SP1(=S)SP2(=S)S3 CYQAYERJWZKYML-UHFFFAOYSA-N 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920000137 polyphosphoric acid Polymers 0.000 description 1
- 239000004323 potassium nitrate Substances 0.000 description 1
- 235000010333 potassium nitrate Nutrition 0.000 description 1
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- RVQZKNOMKUSGCI-UHFFFAOYSA-N pyridine-4-carbonyl chloride Chemical compound ClC(=O)C1=CC=NC=C1 RVQZKNOMKUSGCI-UHFFFAOYSA-N 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000006798 ring closing metathesis reaction Methods 0.000 description 1
- 150000003335 secondary amines Chemical class 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 125000005624 silicic acid group Chemical class 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- JVBXVOWTABLYPX-UHFFFAOYSA-L sodium dithionite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])=O JVBXVOWTABLYPX-UHFFFAOYSA-L 0.000 description 1
- 239000004289 sodium hydrogen sulphite Substances 0.000 description 1
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- GRVFOGOEDUUMBP-UHFFFAOYSA-N sodium sulfide (anhydrous) Chemical compound [Na+].[Na+].[S-2] GRVFOGOEDUUMBP-UHFFFAOYSA-N 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 235000011150 stannous chloride Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- HXJUTPCZVOIRIF-UHFFFAOYSA-N sulfolane Chemical compound O=S1(=O)CCCC1 HXJUTPCZVOIRIF-UHFFFAOYSA-N 0.000 description 1
- 125000004434 sulfur atom Chemical group 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 239000011135 tin Substances 0.000 description 1
- 229910052718 tin Inorganic materials 0.000 description 1
- AXZWODMDQAVCJE-UHFFFAOYSA-L tin(II) chloride (anhydrous) Chemical compound [Cl-].[Cl-].[Sn+2] AXZWODMDQAVCJE-UHFFFAOYSA-L 0.000 description 1
- 125000002088 tosyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C([H])([H])[H])S(*)(=O)=O 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 125000000026 trimethylsilyl group Chemical class [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 235000019871 vegetable fat Nutrition 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/34—Oxygen atoms in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/96—Spiro-condensed ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/10—Spiro-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19843417643 DE3417643A1 (de) | 1984-05-12 | 1984-05-12 | Neue pyrrolo-benzimidazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel sowie zwischenprodukte |
| DE19843446417 DE3446417A1 (de) | 1984-12-20 | 1984-12-20 | Neue pyrrolo-benzimidazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel sowie zwischenprodukte |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO851862L true NO851862L (no) | 1985-11-13 |
Family
ID=25821132
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO851862A NO851862L (no) | 1984-05-12 | 1985-05-10 | Fremgangsmaate ved fremstilling av nye pyrrolobenzimidazoler |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US4666923A (el) |
| EP (1) | EP0161632B1 (el) |
| JP (2) | JPH0647593B2 (el) |
| KR (1) | KR870001201B1 (el) |
| AU (1) | AU560349B2 (el) |
| DE (1) | DE3582447D1 (el) |
| DK (1) | DK209585A (el) |
| ES (1) | ES542976A0 (el) |
| FI (1) | FI81351C (el) |
| GR (1) | GR851085B (el) |
| HU (1) | HU193754B (el) |
| IL (1) | IL75120A (el) |
| NO (1) | NO851862L (el) |
| NZ (1) | NZ212005A (el) |
| PH (1) | PH22863A (el) |
| PL (2) | PL147842B1 (el) |
| PT (1) | PT80425B (el) |
| SU (1) | SU1480770A3 (el) |
Families Citing this family (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL147842B1 (en) * | 1984-05-12 | 1989-08-31 | Method of obtaining novel pyroisobenzimidazoles | |
| DE3445669A1 (de) * | 1984-12-14 | 1986-06-19 | Boehringer Mannheim Gmbh, 6800 Mannheim | Neue pyrrolo-benzimidazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
| DE3501497A1 (de) * | 1985-01-18 | 1986-07-24 | Boehringer Mannheim Gmbh, 6800 Mannheim | Neue pyrrolo-benzimidazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel sowie zwischenprodukte |
| DE3524067A1 (de) * | 1985-07-05 | 1987-01-08 | Boehringer Mannheim Gmbh | Neue benzimidazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel sowie zwischenprodukte |
| DE3530825A1 (de) * | 1985-08-29 | 1987-03-05 | Boehringer Mannheim Gmbh | Neue benzodipyrrole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
| DE3531678A1 (de) * | 1985-09-05 | 1987-03-12 | Boehringer Mannheim Gmbh | Neue pyrrolo-benzimidazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
| DE3626664A1 (de) * | 1986-08-07 | 1988-02-11 | Boehringer Mannheim Gmbh | Tricyclische benzotriazole, verfahren zu ihrer herstellung sowie arzneimittel |
| DE3639466A1 (de) * | 1986-11-18 | 1988-05-19 | Thomae Gmbh Dr K | Neue pyrrolo-benzimidazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
| DE3642315A1 (de) * | 1986-12-11 | 1988-06-23 | Boehringer Mannheim Gmbh | Neue pyrrolobenzimidazole, verfahren zu ihrer herstellung sowie arzneimittel |
| DE3740985A1 (de) * | 1987-12-03 | 1989-06-15 | Boehringer Mannheim Gmbh | Verwendung linear anellierter tricyclen als hemmer der erythrozytenaggregation |
| US4963677A (en) * | 1987-12-30 | 1990-10-16 | Orion Corporation Ltd. | Heterocyclic lactam compounds |
| DE3855327D1 (de) * | 1987-12-30 | 1996-07-04 | Orion Yhtymae Oy | Heterocyclische Verbindungen |
| DE3803775A1 (de) * | 1988-02-09 | 1989-08-17 | Boehringer Mannheim Gmbh | Neue substituierte lactame, verfahren zu ihrer herstellung und arzneimittel, die diese verbindungen enthalten |
| US5324911A (en) * | 1990-01-08 | 1994-06-28 | Schroer Manufacturing Company | Heated animal surgery table |
| DE4027592A1 (de) * | 1990-08-31 | 1992-03-05 | Beiersdorf Ag | Neue pyrrolobenzimidazole, imidazobenzoxazinone und imidazochinolone, verfahren zu ihrer herstellung und ihre verwendung sowie die verbindungen enthaltende zubereitungen |
| US7772188B2 (en) | 2003-01-28 | 2010-08-10 | Ironwood Pharmaceuticals, Inc. | Methods and compositions for the treatment of gastrointestinal disorders |
| US20060142247A1 (en) * | 2004-12-17 | 2006-06-29 | Guy Georges | Tricyclic heterocycles |
| CN101160312A (zh) * | 2005-04-14 | 2008-04-09 | 霍夫曼-拉罗奇有限公司 | 三环吡咯衍生物、它们的制备和作为药剂的应用 |
| WO2006108489A1 (en) * | 2005-04-14 | 2006-10-19 | F. Hoffmann-La Roche Ag | Aminopyrazole derivatives, their manufacture and use as pharmaceutical agents |
| AU2006326247A1 (en) * | 2005-12-15 | 2007-06-21 | F. Hoffmann-La Roche Ag | Tricyclic lactam derivatives, their manufacture and use as pharmaceutical agents |
| CN101400681A (zh) * | 2006-03-23 | 2009-04-01 | 霍夫曼-拉罗奇有限公司 | 取代的吲唑衍生物，它们的制备和作为药剂的应用 |
| US8063225B2 (en) * | 2006-08-14 | 2011-11-22 | Chembridge Corporation | Tricyclic compound derivatives useful in the treatment of neoplastic diseases, inflammatory disorders and immunomodulatory disorders |
| MX354786B (es) | 2007-06-04 | 2018-03-21 | Synergy Pharmaceuticals Inc | Agonistas de guanilato ciclasa utiles para el tratamiento de trastornos gastrointestinales, inflamacion, cancer y otros trastornos. |
| US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
| CA2726917C (en) | 2008-06-04 | 2018-06-26 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
| WO2010009319A2 (en) | 2008-07-16 | 2010-01-21 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders |
| US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
| RU2443704C1 (ru) * | 2010-10-29 | 2012-02-27 | Федеральное государственное автономное образовательное учреждение высшего профессионального образования "ЮЖНЫЙ ФЕДЕРАЛЬНЫЙ УНИВЕРСИТЕТ" | СУЛЬФАТЫ 2-АРИЛ-4-ДИАЛКИЛАМИНОЭТИЛ-3-ФЕНИЛПИРРОЛО[1,2-a]-БЕНЗИМИДАЗОЛОВ, ОБЛАДАЮЩИЕ АНТИОКСИДАНТНЫМИ И АНТИРАДИКАЛЬНЫМИ СВОЙСТВАМИ |
| US9580471B2 (en) | 2011-03-01 | 2017-02-28 | Synergy Pharmaceuticals, Inc. | Process of preparing guanylate cyclase C agonists |
| JP6116693B2 (ja) | 2012-09-13 | 2017-04-19 | エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ | Ｃｎｓ障害の処置のための２−オキソ−２，３−ジヒドロ−インドール |
| US9545446B2 (en) | 2013-02-25 | 2017-01-17 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase and their uses |
| WO2014151200A2 (en) | 2013-03-15 | 2014-09-25 | Synergy Pharmaceuticals Inc. | Compositions useful for the treatment of gastrointestinal disorders |
| EP2970384A1 (en) | 2013-03-15 | 2016-01-20 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase and their uses |
| JP6606491B2 (ja) | 2013-06-05 | 2019-11-13 | シナジー ファーマシューティカルズ インコーポレイテッド | グアニル酸シクラーゼｃの超高純度アゴニスト、その作成および使用方法 |
| JP6694385B2 (ja) | 2013-08-09 | 2020-05-13 | アーデリクス，インコーポレーテッド | リン酸塩輸送阻害のための化合物及び方法 |
| GB201709456D0 (en) * | 2017-06-14 | 2017-07-26 | Ucb Biopharma Sprl | Therapeutic agents |
| WO2020237096A1 (en) | 2019-05-21 | 2020-11-26 | Ardelyx, Inc. | Combination for lowering serum phosphate in a patient |
| JP6854953B1 (ja) | 2020-06-16 | 2021-04-07 | 株式会社ソディック | ワイヤ放電加工装置 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1158532A (en) * | 1967-01-05 | 1969-07-16 | Centre Nat Rech Scient | 2-Oxoindoline-3-Carboxylic Acids and Esters thereof |
| BE714717A (el) * | 1967-05-12 | 1968-09-30 | ||
| FR1529901A (fr) * | 1967-05-12 | 1968-06-21 | Centre Nat Rech Scient | Procédé de préparation de lactames se rattachant à l'indolinone et à l'oxo quinoléine |
| US4322533A (en) * | 1980-03-17 | 1982-03-30 | Lesher George Y | 1H-Indole-2,3-dione derivatives |
| CH644116A5 (de) * | 1980-08-21 | 1984-07-13 | Hoffmann La Roche | Imidazolderivate. |
| DE3224512A1 (de) * | 1982-07-01 | 1984-01-05 | Dr. Karl Thomae Gmbh, 7950 Biberach | Neue imidazolderivate, ihre herstellung und diese verbindungen enthaltende arzneimittel |
| PL147842B1 (en) * | 1984-05-12 | 1989-08-31 | Method of obtaining novel pyroisobenzimidazoles |
-
1985
- 1985-05-06 PL PL1985259261A patent/PL147842B1/pl unknown
- 1985-05-06 PL PL1985253246A patent/PL144822B1/pl unknown
- 1985-05-06 GR GR851085A patent/GR851085B/el unknown
- 1985-05-07 IL IL75120A patent/IL75120A/xx unknown
- 1985-05-07 US US06/731,500 patent/US4666923A/en not_active Expired - Lifetime
- 1985-05-07 NZ NZ212005A patent/NZ212005A/xx unknown
- 1985-05-08 PH PH32240A patent/PH22863A/en unknown
- 1985-05-09 KR KR1019850003144A patent/KR870001201B1/ko not_active IP Right Cessation
- 1985-05-09 DE DE8585105675T patent/DE3582447D1/de not_active Expired - Lifetime
- 1985-05-09 EP EP85105675A patent/EP0161632B1/de not_active Expired - Lifetime
- 1985-05-09 AU AU42222/85A patent/AU560349B2/en not_active Ceased
- 1985-05-09 PT PT80425A patent/PT80425B/pt not_active IP Right Cessation
- 1985-05-09 ES ES542976A patent/ES542976A0/es active Granted
- 1985-05-10 HU HU851775A patent/HU193754B/hu not_active IP Right Cessation
- 1985-05-10 FI FI851869A patent/FI81351C/fi not_active Application Discontinuation
- 1985-05-10 SU SU853894709A patent/SU1480770A3/ru active
- 1985-05-10 NO NO851862A patent/NO851862L/no unknown
- 1985-05-10 DK DK209585A patent/DK209585A/da not_active Application Discontinuation
- 1985-05-13 JP JP60099742A patent/JPH0647593B2/ja not_active Expired - Lifetime
-
1988
- 1988-07-05 US US07/217,143 patent/US4963686A/en not_active Expired - Fee Related
-
1993
- 1993-12-10 JP JP5310823A patent/JPH0772185B2/ja not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| ES8603178A1 (es) | 1986-01-01 |
| JPH0741474A (ja) | 1995-02-10 |
| IL75120A0 (en) | 1985-09-29 |
| JPH0647593B2 (ja) | 1994-06-22 |
| FI81351C (fi) | 1990-10-10 |
| US4666923A (en) | 1987-05-19 |
| EP0161632A2 (de) | 1985-11-21 |
| AU4222285A (en) | 1985-11-14 |
| AU560349B2 (en) | 1987-04-02 |
| EP0161632B1 (de) | 1991-04-10 |
| PT80425A (de) | 1985-06-01 |
| JPH0772185B2 (ja) | 1995-08-02 |
| KR850008170A (ko) | 1985-12-13 |
| FI81351B (fi) | 1990-06-29 |
| PT80425B (de) | 1987-04-16 |
| PH22863A (en) | 1989-01-19 |
| US4963686A (en) | 1990-10-16 |
| GR851085B (el) | 1985-11-25 |
| PL253246A1 (en) | 1986-08-26 |
| SU1480770A3 (ru) | 1989-05-15 |
| EP0161632A3 (en) | 1986-06-11 |
| JPS60246386A (ja) | 1985-12-06 |
| FI851869L (fi) | 1985-11-13 |
| DK209585A (da) | 1985-11-13 |
| HU193754B (en) | 1987-11-30 |
| KR870001201B1 (ko) | 1987-06-20 |
| IL75120A (en) | 1989-02-28 |
| FI851869A0 (fi) | 1985-05-10 |
| PL144822B1 (en) | 1988-07-30 |
| DK209585D0 (da) | 1985-05-10 |
| HUT37938A (en) | 1986-03-28 |
| ES542976A0 (es) | 1986-01-01 |
| PL147842B1 (en) | 1989-08-31 |
| NZ212005A (en) | 1989-07-27 |
| DE3582447D1 (de) | 1991-05-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO851862L (no) | Fremgangsmaate ved fremstilling av nye pyrrolobenzimidazoler | |
| US4731358A (en) | β-carbolines and their use as tranquilizers | |
| IE58696B1 (en) | 9-Amino-1,2,3,4-tetrahydroacridin-1-ol and related compounds, a process for their preparation and their use as medicaments | |
| EP0260817A1 (en) | Quinazolinediones and pyridopyrimidinediones | |
| NO179748B (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive bis-(1H-indol-3-yl)-maleinimidderivater | |
| US3993656A (en) | 1,8-Naphthyridine compounds | |
| EP0344634B1 (de) | Bicyclische Carboxamide, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel | |
| DE2334266A1 (de) | Pyrido eckige klammer auf 2,3-d eckige klammer zu pyrimidin-2,4 (1h, 3h)-dione | |
| DD267047A5 (de) | Verfahren zur herstellung von pyrrolobenzimidazolen | |
| DK165744B (da) | Thienopyrimidinderivater, fremgangsmaader til fremstilling deraf og farmaceutiske praeparater | |
| JPH0471914B2 (el) | ||
| EP0053789B1 (en) | 2-pyridinecarboxamide derivative, process for preparing same and pharmaceutical composition, useful as an anti-allergic agent | |
| US4912104A (en) | Tricyclic fused pryimidine derivatives, and their use as pharmaceuticals | |
| DD253821A5 (de) | Verfahren zur herstellung von pyrrolo-benzimidozolen, pyrrolo-benzooxazolen und pyrrolo-benzthiozole | |
| US4801590A (en) | Pyrido(1,8)naphthyridinones, and their use as pharmaceuticals | |
| US4797403A (en) | Quinazolinediones and pyridopyrimidinediones | |
| US4482714A (en) | Pyrazino[2',3'-3,4]pyrido[1,2-a]indole derivatives | |
| US3595874A (en) | 3,4,5,10-tetrahydroazepino(2,3-b)indol-5a (2h)-ols | |
| US4515949A (en) | [2-(1H-indol-1-yl)ethyl]-2-piperazine and pyrido[1,2-a]indol-9-one as intermediates for pyrazino(2,3-3,4)pyrido(1,2-a) indoles which are useful for treating hypertension in mammals | |
| NO874780L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrrolo-benzimidazol-derivater. | |
| DD234867A5 (de) | Neue pyrrolo-benzimidazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel sowie zwischenprodukte | |
| EP0033660A1 (en) | 2-(1-Piperazinyl)-cycloheptimidazole derivatives, processes for their preparation, pharmaceutical compositions containing them, and the preparation of such compositions | |
| US4002638A (en) | Benzazepine derivatives | |
| US3444174A (en) | Substituted 4,7-dihydroindoles | |
| Cignarella et al. | On the behavior of α‐brominated dimethyl o‐benzenediacetate toward nitrogen nucleophiles. Part II. Reaction of dimethyl α‐bromo‐o‐benzenediacetate with hydrazines |